Research Progress to Date (Jan. 2018)

The main focus of the GCS Project’s research initiative has been to characterize the genetic and epigenetic landscape of a group of primary and metastatic carcinosarcoma tumor samples. Please see The Science section for an explanation of how and why we’re doing this.


To date we have been able to begin performing next-generation sequencing and DNA methylation studies on over 100 tumor samples. The majority of the sequencing is complete and there will be about 1-2 months required for analysis of the large amount of data generated. 


This work has only been possible thanks to the overwhelming support the GCS Project has received through generous donations from the amazing community that has formed around this group. Looking forward, we hope to expand the sequencing efforts to include more tumor samples and utilize more advanced sequencing technologies, such as whole genome sequencing or single cell sequencing technologies. This research will also lead into the development of clinical trials which require significant funding resources. We hope to have your continued support throughout this mission and whatever comes next!